Men's Formula 1 Capsules
Natural health product licensed in Canada
- Licence holder
- BioV Pharma Inc.
- NPN or DIN-HM
- 80068108
- Status
- Inactive licence
- Licence date
- 30 March 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 15 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 15 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSA for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide L-glutamique Source : Acide glutamique | 75 milligramme | Not calculated |
| Zinc Source : Produit de chélation de zinc et d'acide aminée | 50 milligramme | 50,000 µg |
| Serenoa repens Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 800 milligramme Potency : 45 % Fatty acids | 200 milligramme | Not calculated |
| 2-(3,4-dihydroxyphényl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Source : Quercétine dihydraté | 40 milligramme | Not calculated |
| Sélénium Source : Sélénométhionine | 20 microgrammes | Not calculated |
| Prunus africana Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 80 milligramme Potency : 2.5 % Phytosterols | 20 milligramme | Not calculated |
| Urtica dioica Source : Feuille | 30 milligramme | Not calculated |
| Cucurbita pepo Source : Cucurbita pepo - Graine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 milligramme | 50 milligramme | Not calculated |
| Vitamine C Source : Acide ascorbique | 30 milligramme | 30,000 µg |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 23 mg AT | Not calculated |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 50 UI | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 15 milligramme | 15,000 µg |
| Allium sativum Source : Bulbe | 10 milligramme | Not calculated |
Non-medicinal ingredients
Extrait de pollen, Dioxyde de silicium, Maltodextrine, Stéarate de magnésium, Gélatine, Bêta-sitostérol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Helps to maintain normal DNA synthesis. Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are taking thiazide diuretics, cardiac glycosides, corticosteroids, stimulant laxatives or other medications which may aggravate electrolyte imbalance. Do not use if you have hypokalemia, high blood pressure, or a kidney or cardiovascular disorder. If you have hypotension, do not use this product.
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have a liver disorder. Consult a health care practitioner prior to use if you have an auto-immune disorder. In case of qi or blood deficiency, consult a health care practitioner prior to us. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use to exclude a diagnosis of prostate cancer.
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use. Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use.
Source
Official Health Canada record, licence 80068108
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.